News
The first recall affects tuna salad and ready-to-eat foods containing tuna salad sold at Jewel-Osco (which is owned by ...
Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that ...
Replimune (NASDAQ:REPL) announced on Tuesday that the U.S. Food and Drug Administration (FDA) issued a Complete Response ...
The Food and Drug Administration has identified a Class I recall of certain lots of Medline Industries Craniotomy ...
The FDA's assessment of the bread recall has designated it as a Class II risk, which means the product "may cause temporary ...
Tidmarsh, who has founded and served as CEO of several biotech companies, will lead a crucial FDA division that reviews the ...
Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the agency’s ...
The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner ...
Thursday’s authorization, following a multiyear FDA review, has come under scrutiny, including from Yolanda Richardson, ...
George Tidmarsh, a Stanford University physician who founded Horizon Pharma and later ran La Jolla Pharma, was named head of ...
The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...
FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results